Literature DB >> 4364209

Recurrent herpes genitalis. Treatment with Mycobacterium bovis (BCG).

F D Anderson, R N Ushijima, C L Larson.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4364209

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  11 in total

1.  Antiviral effect of pyran against systemic infection of mice with herpes simplex virus type 2.

Authors:  R S McCord; M K Breinig; P S Morahan
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

2.  Resistance to vaginal or systemic infection with herpes simplex virus type 2.

Authors:  M C Breinig; L L Wright; M B McGeorge; P S Morahan
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

Review 3.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

4.  Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes.

Authors:  J M Douglas; L A Vontver; W E Stamm; W C Reeves; C Critchlow; M L Remington; K K Holmes; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

5.  Epidemiologic study of a leukocyte-transforming agent in a general population.

Authors:  C V Sumaya
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

6.  Effect of pyran on latency after herpes simplex virus infections.

Authors:  P S Morahan; P F Cline; M C Breinig; B K Murray
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

Review 7.  Genital herpes simplex.

Authors:  I S Tummon; D K Dudley; J H Walters
Journal:  Can Med Assoc J       Date:  1981-07-01       Impact factor: 8.262

Review 8.  Bacillus Calmette-Guerin (BCG): the adroit vaccine.

Authors:  Oluwafolajimi A Adesanya; Christabel I Uche-Orji; Yeshua A Adedeji; John I Joshua; Adeniyi A Adesola; Chibuike J Chukwudike
Journal:  AIMS Microbiol       Date:  2021-02-08

Review 9.  BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander?

Authors:  Khalid Muhammad; Helal F Hetta; Gopala Koneru; Gaber El-Saber Batiha; Abdelazeem M Algammal; Mahmoud Mabrok; Sara Magdy; Shrouk Sayed; Mai E AbuElmagd; Reham Elnemr; Mahmoud M Saad; Noura H Abd Ellah; Amal Hosni
Journal:  Infect Drug Resist       Date:  2021-03-23       Impact factor: 4.003

Review 10.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.